undamentalytics Newsletter
Sign in

Pelthos Therapeutics Inc. balance sheet

At the end of fiscal 2025, Pelthos Therapeutics Inc. had total assets of $130m, total liabilities of $91.5m and shareholders' equity of $38.9m. It held $18.0m in cash against $31.4m of debt: net debt of $13.5m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents11824
Receivables0914
Inventory02421
Total current assets15363
Goodwill02525
Total assets1130137
Accounts payable236
Deferred revenue (current)011
Total current liabilities42632
Total debt03143
Total liabilities492139
Shareholders' equity−339−2
Net debt (negative = net cash)−11319
Shares outstanding——4m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BFRI vs PTHSCPIX vs PTHSIMCC vs PTHS

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pelthos Therapeutics Inc.